Biotron publishes SARS research
Thursday, 11 November, 2004
The researchers at Biotron and the John Curtin School of Medical Research at ANU showed that the SARS coronavirus E protein forms ion channels.
Based on the research, Biotron has developed a screening test for the E protein and has screened its compound library for activity against the SARS E protein as well as other members of the coronavirus family, which are responsible for about 25 per cent of colds as well as other diseases. The company has identified a number of compounds with good activity, which are able to inhibit the replication of the SARS virus.
The work has been supported by a Commonwealth government BIF grant awarded to Biotron in November last year to support the development of the company's Virion platform technology.
Scientists search for cystitis pain 'off switch'
By targeting certain pain receptors in the bladder, Australian scientists believe that the...
Australia's first cases of H5 avian influenza confirmed
Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...
AusBiotech partners with Tenmile
Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced...
